STACEY PANASCI: Open Payments
NPI 1508048430 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,903 in 194 payments from 11 companies in 2025. Trend: 2023 $14,882 · 2024 $12,783 · 2025 $31,903
Speaker / faculty: $19,268Consulting: $6,143Food & beverage: $3,787Travel & lodging: $2,687Education: $19
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 51 | $18,213 |
| Biogen, Inc. | 25 | $6,086 |
| Novartis Pharmaceuticals Corporation | 31 | $6,043 |
| ABBVIE INC. | 45 | $413 |
| Genentech USA, Inc. | 10 | $390 |
| EMD Serono, Inc. | 17 | $351 |
| Celgene Corporation | 11 | $314 |
| Genentech, Inc. | 1 | $34 |
| PFIZER INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
Products named: BRIUMVI, KESIMPTA, VUMERITY, TYSABRI, ZEPOSIA, UBRELVY, Ocrevus, Ocrevus Zunovo.
Industry payments across MA — which companies pay providers there.
